Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma

Qing Lan, Tongzhang Zheng, Stephen Chanock, Yawei Zhang, Min Shen, Sophia S. Wang, Sonja I. Berndt, Shelia H. Zahm, Theodore R. Holford, Brian Leaderer, Meredith Yeager, Robert Welch, Howard D. Hosgood, Peter Boyle, Nathaniel Rothman

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The caspase proteins are essential for the regulation of normal B cell development and regulation of apoptosis. We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based case-control study of women in Connecticut (461 cases and 535 controls). Variants in CASP3 and CASP9 were significantly associated with a decreased risk for NHL, particularly follicular lymphoma [e.g. CASP3 Ex8+567T>C odds ratio (OR) CC+TC = 0.4, 95% confidence interval (CI) = 0.3-0.7; and CASP9 Ex5+32G>A OR AA+AG = 0.6, 95% CI = 0.4-1.0]. Further, variants in CASP3, CASP8 and CASP10 were associated with a decreased risk of marginal zone lymphoma and variants in CASP3 and CASP10 were associated with a lower risk of chronic lymphocytic leukemia and related subtypes. The striking protective associations observed for polymorphisms in all four genes for NHL and/or one or more subtypes suggest that genetic variation in CASP genes may play an important role in the etiology of NHL.

Original languageEnglish (US)
Pages (from-to)823-827
Number of pages5
JournalCarcinogenesis
Volume28
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Caspases
Caspase 3
Non-Hodgkin's Lymphoma
Genes
Odds Ratio
Confidence Intervals
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Single Nucleotide Polymorphism
Case-Control Studies
Lymphoma
B-Lymphocytes
Apoptosis
Population
Proteins

ASJC Scopus subject areas

  • Cancer Research

Cite this

Lan, Q., Zheng, T., Chanock, S., Zhang, Y., Shen, M., Wang, S. S., ... Rothman, N. (2007). Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis, 28(4), 823-827. https://doi.org/10.1093/carcin/bgl196

Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. / Lan, Qing; Zheng, Tongzhang; Chanock, Stephen; Zhang, Yawei; Shen, Min; Wang, Sophia S.; Berndt, Sonja I.; Zahm, Shelia H.; Holford, Theodore R.; Leaderer, Brian; Yeager, Meredith; Welch, Robert; Hosgood, Howard D.; Boyle, Peter; Rothman, Nathaniel.

In: Carcinogenesis, Vol. 28, No. 4, 04.2007, p. 823-827.

Research output: Contribution to journalArticle

Lan, Q, Zheng, T, Chanock, S, Zhang, Y, Shen, M, Wang, SS, Berndt, SI, Zahm, SH, Holford, TR, Leaderer, B, Yeager, M, Welch, R, Hosgood, HD, Boyle, P & Rothman, N 2007, 'Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma', Carcinogenesis, vol. 28, no. 4, pp. 823-827. https://doi.org/10.1093/carcin/bgl196
Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, Wang SS et al. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis. 2007 Apr;28(4):823-827. https://doi.org/10.1093/carcin/bgl196
Lan, Qing ; Zheng, Tongzhang ; Chanock, Stephen ; Zhang, Yawei ; Shen, Min ; Wang, Sophia S. ; Berndt, Sonja I. ; Zahm, Shelia H. ; Holford, Theodore R. ; Leaderer, Brian ; Yeager, Meredith ; Welch, Robert ; Hosgood, Howard D. ; Boyle, Peter ; Rothman, Nathaniel. / Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. In: Carcinogenesis. 2007 ; Vol. 28, No. 4. pp. 823-827.
@article{cd9db923b7904190b9abdef2d4964555,
title = "Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma",
abstract = "The caspase proteins are essential for the regulation of normal B cell development and regulation of apoptosis. We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based case-control study of women in Connecticut (461 cases and 535 controls). Variants in CASP3 and CASP9 were significantly associated with a decreased risk for NHL, particularly follicular lymphoma [e.g. CASP3 Ex8+567T>C odds ratio (OR) CC+TC = 0.4, 95{\%} confidence interval (CI) = 0.3-0.7; and CASP9 Ex5+32G>A OR AA+AG = 0.6, 95{\%} CI = 0.4-1.0]. Further, variants in CASP3, CASP8 and CASP10 were associated with a decreased risk of marginal zone lymphoma and variants in CASP3 and CASP10 were associated with a lower risk of chronic lymphocytic leukemia and related subtypes. The striking protective associations observed for polymorphisms in all four genes for NHL and/or one or more subtypes suggest that genetic variation in CASP genes may play an important role in the etiology of NHL.",
author = "Qing Lan and Tongzhang Zheng and Stephen Chanock and Yawei Zhang and Min Shen and Wang, {Sophia S.} and Berndt, {Sonja I.} and Zahm, {Shelia H.} and Holford, {Theodore R.} and Brian Leaderer and Meredith Yeager and Robert Welch and Hosgood, {Howard D.} and Peter Boyle and Nathaniel Rothman",
year = "2007",
month = "4",
doi = "10.1093/carcin/bgl196",
language = "English (US)",
volume = "28",
pages = "823--827",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma

AU - Lan, Qing

AU - Zheng, Tongzhang

AU - Chanock, Stephen

AU - Zhang, Yawei

AU - Shen, Min

AU - Wang, Sophia S.

AU - Berndt, Sonja I.

AU - Zahm, Shelia H.

AU - Holford, Theodore R.

AU - Leaderer, Brian

AU - Yeager, Meredith

AU - Welch, Robert

AU - Hosgood, Howard D.

AU - Boyle, Peter

AU - Rothman, Nathaniel

PY - 2007/4

Y1 - 2007/4

N2 - The caspase proteins are essential for the regulation of normal B cell development and regulation of apoptosis. We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based case-control study of women in Connecticut (461 cases and 535 controls). Variants in CASP3 and CASP9 were significantly associated with a decreased risk for NHL, particularly follicular lymphoma [e.g. CASP3 Ex8+567T>C odds ratio (OR) CC+TC = 0.4, 95% confidence interval (CI) = 0.3-0.7; and CASP9 Ex5+32G>A OR AA+AG = 0.6, 95% CI = 0.4-1.0]. Further, variants in CASP3, CASP8 and CASP10 were associated with a decreased risk of marginal zone lymphoma and variants in CASP3 and CASP10 were associated with a lower risk of chronic lymphocytic leukemia and related subtypes. The striking protective associations observed for polymorphisms in all four genes for NHL and/or one or more subtypes suggest that genetic variation in CASP genes may play an important role in the etiology of NHL.

AB - The caspase proteins are essential for the regulation of normal B cell development and regulation of apoptosis. We investigated five single nucleotide polymorphisms in four key caspase genes, CASP3 [Ex8-280C>A (rs6948) and Ex8+567T>C (rs1049216)], CASP8 Ex14-271A>T (rs13113), CASP9 Ex5+32G>A (rs1052576) and CASP10 Ex3-171A>G (rs3900115) to determine whether they alter risk for non-Hodgkin lymphoma (NHL) in a population-based case-control study of women in Connecticut (461 cases and 535 controls). Variants in CASP3 and CASP9 were significantly associated with a decreased risk for NHL, particularly follicular lymphoma [e.g. CASP3 Ex8+567T>C odds ratio (OR) CC+TC = 0.4, 95% confidence interval (CI) = 0.3-0.7; and CASP9 Ex5+32G>A OR AA+AG = 0.6, 95% CI = 0.4-1.0]. Further, variants in CASP3, CASP8 and CASP10 were associated with a decreased risk of marginal zone lymphoma and variants in CASP3 and CASP10 were associated with a lower risk of chronic lymphocytic leukemia and related subtypes. The striking protective associations observed for polymorphisms in all four genes for NHL and/or one or more subtypes suggest that genetic variation in CASP genes may play an important role in the etiology of NHL.

UR - http://www.scopus.com/inward/record.url?scp=34047141698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047141698&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgl196

DO - 10.1093/carcin/bgl196

M3 - Article

VL - 28

SP - 823

EP - 827

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 4

ER -